Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for funds unlawfully withheld for five years, AHA today asked to meet with the responsible HHS team to discuss its forthcoming remedial proposal. The letter also offered five guiding principles in the hope of expediting this administrative process and avoiding further legal challenges. 

Specifically, the letter calls for HHS to: 

鈥    Repay each 340B hospital the full amount that was unlawfully withheld between January 2018 and September 2022;
鈥    Repay each 340B hospital promptly;
鈥    Not impose a prospective remedy; 
鈥    Pay hospitals interest on its underpayments until they are fully repaid; and 
鈥    Not recoup funds from the hospital field to achieve budget neutrality. 

鈥淎s the AHA has stated before, we are willing to work with HHS to assure a fair and equitable resolution of these issues, which have already taken far too long to resolve, at great cost to the entire hospital field,鈥 the AHA letter states. 鈥淲orking together, HHS and the AHA can develop a fair and administrable remedy that avoids further legal or administrative delay.鈥

View the AHA letter for more details on each of these principles. 

Related News Articles

Headline
The AHA, joined by several other national groups representing 340B hospitals, Aug. 8 urged the Health Resources and Services Administration to extend the鈥
Headline
The AHA today filed an amicus brief in the U.S. Court of Appeals for the D.C. Circuit, defending the Department of Health and Human Services鈥 decision to鈥
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug鈥
Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'鈥
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state鈥檚 340B contract pharmacy law prohibiting鈥
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state鈥檚 340B contract鈥